Literature DB >> 26220456

Biological Perspectives: Anti-NMDA Receptor Encephalitis.

Jonathan S Dowben1, Peter C Kowalski2, Norman L Keltner3.   

Abstract

PURPOSE: This article explores the recently recognized anti-NMDA receptor encephalitis, which may produce psychiatric symptoms.
CONCLUSIONS: Historically, some patients presenting for psychiatric care may have actually been suffering from anti-NMDA encephalitis; thus, awareness of this disorder may facilitate appropriate treatment. TREATMENT IMPLICATIONS: Early diagnosis and aggressive treatment promote better outcomes. First-line treatment includes immunotherapy.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Encephalitis; NMDA receptors; glutamate

Mesh:

Substances:

Year:  2015        PMID: 26220456     DOI: 10.1111/ppc.12132

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  3 in total

Review 1.  Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies.

Authors:  Ding Chen; Sandra Gallagher; Nancy L Monson; Ronald Herbst; Yue Wang
Journal:  J Clin Med       Date:  2016-11-24       Impact factor: 4.241

2.  Chronic Neuropsychological Sequelae in a Patient with Nontumorous Anti-NMDA-Receptor Encephalitis.

Authors:  Dong Y Han; Lisa M Koehl; Aarti Patel; Zhengqiu Zhou; Sarah Phillips; Siddharth Kapoor
Journal:  Case Rep Neurol Med       Date:  2017-04-19

3.  Hemiataxia: A Novel Presentation of Anti-NMDA Receptor Antibody Mediated Encephalitis in an Adolescent.

Authors:  Greg D Phillips; Gillian N Jones; Maureen Callaghan; Marc P DiFazio
Journal:  Case Rep Psychiatry       Date:  2017-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.